FDA clears Think Surgical robotic system for use with Medacta knee implants
Click Here to Manage Email Alerts
Key takeaways:
- Think Surgical Inc. received FDA clearance for its robotic system to be used with Medacta knee systems.
- Think Surgical and Medacta announced a collaboration agreement on Aug. 29.
Think Surgical Inc. announced it received FDA 510(k) clearance for its TMINI miniature robotic system to be used with the GMK sphere and SpheriKA knee systems from Medacta, according to a company press release.
“Medacta’s commitment to innovation aligns well with Think Surgical’s dedication to
,” Stuart Simpson, president and CEO of Think Surgical, said in the release. “We are excited to partner with Medacta in the U.S. to offer customers greater
.”
The collaboration agreement between Think Surgical and Medacta will combine the robotic surgery platform and knee systems for patients undergoing robotic-assisted total knee replacement.
“I am pleased to announce our collaboration with Think Surgical in the U.S. market,” Matt Goudy, managing director and president of Medacta USA, said in the release. “This partnership marks another step forward in our commitment to offering cutting-edge technologies that drive sustainable innovation forward and enhance our ability to deliver personalized solutions for surgeons and patients worldwide.”
Read more about
Click Here to Manage Email Alerts